AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)
AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)

Financial Summary LCI Quote Lannett Co

Lannett Co Inc Quote

Lannett Co Inc (LCI)

5.22 0.01 Healthcare
Stock Performance rating :
Recommendation :
Not Available
Symbol LCI
Price 5.22
Beta 2.43
Vol Avg 720.49 K
Mkt cap 199.02 M
Shares 37
Last Div Not Available
Div Yield 0.00%
DCF Unlevered Not Available Not Available
DCF Levered Not Available Not Available
ROE Not Available Not Available
ROA Not Available Not Available
Operating Margin Not Available Not Available
Debt/Equity Not Available Not Available
P/E Not Available Not Available
P/B Not Available Not Available
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 151 274 407 0 0
COGS 94 119 100 256 332
GrossProfit 57 154 306 286 301
Depreciation (included in COGS) 0 0 0 0 0
StockBasedCompe (included in COGS) 0 0 0 0 0
ResearchAndDeve 16 28 30 45 42
SalesGeneralAnd 22 39 50 68 73
OperatingIncome 19 88 226 131 86
InterestExpense 0 0 0 66 89
OtherIncome 2 2 1 -3 4
IncomeBeforeTax 21 90 227 62 1
ProvisionForInc 0 0 0 0 0
NetIncome 13 57 150 45 -1
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 43 106 200 225 118
ShortTermInvest 8 41 13 14 27
Cash 51 146 214 0 0
AccountReceivab 26 113 91 0 0
Inventories 33 45 46 0 0
DeferredIncomeT 8 14 12 12 24
OtherCurrentAss 1 -50 3 6 7
TotalCurrentAss 116 266 371 613 524
PPE 71 97 135 270 315
AccumulatedDepr -31 -35 -40 -54 -71
NetPPE 40 62 95 217 243
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 334 340
IntangibleAsset 3 1 29 576 454
OtherLTAssets 1 0 2 14 19
TotalNonCurrent 52 77 138 1,151 1,080
TotalAssets 168 343 509 1,764 1,603
ShortTermDebt 1 0 0 178 60
AccountsPayable 23 21 19 0 0
TaxesPayable 0 5 2 1 0
AccruedLiabilit 10 17 15 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 0 5 8 73 70
TotalCurrentLia 33 47 44 307 192
Debt 6 1 1 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 0 0 0 19 6
TotalNonCurrent 6 1 1 903 850
TotalLiabilitie 39 48 45 1,210 1,042
CommonStock 0 0 0 0 0
AdditionalPaidI 104 217 236 283 293
RetainedEarning 27 84 234 278 278
AccumulatedOthe 0 0 0 0 0
TotalStockholde 129 294 463 554 561
TotalLiabilitie 168 343 509 1,764 1,603
Cash Flow Statement
Year 20142015201620172018
NetIncome 13 57 150 45 -1
Depreciation 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 0 0 0 0 0
AccountsReceiva 0 0 0 0 0
InventoryCS 0 0 0 0 0
AccountsPayable 0 0 0 0 0
OtherWorkingCap 0 0 0 0 0
OtherNonCashIte 0 0 0 0 0
NetCashProvided 0 0 0 0 0
InvestmentsInPP 0 0 0 0 0
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve 0 0 0 0 0
SalesMaturities 0 0 0 0 0
PurchasesOfInta 0 0 0 0 0
OtherInvestingA 0 0 0 0 0
NetCashUsedForI 0 0 0 0 0
DebtIssued 0 0 0 0 0
DebtRepayment 0 0 0 0 0
CommonStockIssu 0 0 0 0 0
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 0 0 0 0 0
NetCashProvided 0 0 0 0 0
NetChangeInCash 0 0 0 0 0
CashAtBeginning 0 0 0 0 0
CashAtEndOfPeri 0 0 0 0 0
Retained Earnings
Year 20142015201620172018
RetainedEarning ---2784
NetIncome --1357150
StockDividend ---40-114-300
DividendPaid -----
RetainedEarning --2784234
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE ---4062
DeprAnnual 0--31-4-5
CapitalExpendit 00000
NetPPE --406295
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0--31
Amortization 0-3145
NewPurchases 0--28-623
intAndGW --3129
Company Profile

CEO

Timothy Crew

Sector

Healthcare

Industry

Drug Manufacturers

Exchange

New York Stock Exchange

Description

Lannett Co Inc develops, manufactures, packages, markets and distributes generic versions of branded pharmaceutical products. Its products include solid oral dosage forms, including oral solutions, nasal, topicals or parentarels.